期刊文献+

乳腺癌易感基因1在食管鳞癌中的表达及临床意义 被引量:2

Expression and clinical significance of BRCA1 in human esophageal squamous cell carcinoma
原文传递
导出
摘要 目的研究食管鳞癌组织中乳腺癌易感基因1(BRCA1)的表达与患者临床病理特征及预后之间的关系。方法采用免疫组织化学染色法检测201例手术切除的T3期食管鳞癌患者癌与癌旁正常组织中BRCA1蛋白的表达。采用,检验分析BRCA1蛋白的表达与患者临床病理特征间的关系,应用Kaplan—Meier法计算累积生存率,以Cox回归模型分析影响预后的因素。结果BRCA1蛋白在食管鳞癌组织中主要定位于细胞质。BRCA1蛋白在食管鳞癌组织中的阳性表达率为88.6%(178/201),明显高于癌旁正常组织[36.8%(74/201),P〈0.001]。BRCA1蛋白的表达与食管鳞癌的大体类型和淋巴结转移有关,其中淋巴结转移的食管鳞癌患者组织中BRCA1蛋白的强阳性表达率(45.0%)明显高于无淋巴结转移者(19.6%,P〈0.001)。Kaplan—Meier生存分析结果显示,BRCA1蛋白强阳性表达的食管鳞癌患者预后较差(P〈0.05)。结论BRCA1蛋白的表达与食管鳞癌的发生发展有关,有可能作为评估食管鳞癌生物学行为的、新的分子标志物。 Objective To investigate the expression of BRCA1 in esophageal squamous cell carcinoma (ESCC) tissues and evaluate its correlation with clinicopathological features as well as the prognosis of ESCC patients. Methods The expression of BRCA1 was detected by immunohistochemistry (IHC) in 201 specimens of T3 stage ESCC tissues and corresponding adjacent normal tissues using tissue microarray. The correlation between BRCA1 expression and clinicopathological features of ESCC was determined by chi-square analysis. The cumulative survival rate was analyzed by Kaplan-Meier method. Results The positive rate of BRCA1 expression in ESCC tissues was significantly higher than that in adjacent normal tissues [ 88.6% ( 178/201 ) vs. 36.8% (74/201), P 〈 0.001 ]. There was a significant correlation between the expression of BRCA1 and lymph node metastasis. In the tumors with positive lymph nodes, strong positive expression of BRCA1 was found in 45.0% (49/109) , while only 19.6% (18/92) in tumors without lymph node metastasis, showing a significant difference ( P 〈 0. 001 ). A close relationship was also found between the expression of BRCA1 and gross typing of tumors (P 〈 0.05). The expression of BRCA1 was not significantly correlated with gender, age, tumor location, differentiation, and tumor thrombus ( P 〉 0.05 ). The results of Kaplan-Meier analysis indicated that ESCC patients with a higher positive rate of BRCA1 expression have a poorer prognosis ( P 〈 0.05 ). Conclusions The expression of BRCA1 is related to the occurrence and development of esophageal carcinoma. BRCA1 protein may serve as a new potential biomarker in estimating the biological behavior of ESCC.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2012年第12期905-909,共5页 Chinese Journal of Oncology
基金 国家“863”重大项目(2006AA02A403) 国家“973”计划项目(2009CB521801)
关键词 乳腺癌易感基因1 食管肿瘤 肿瘤 鳞状细胞 淋巴结 肿瘤转移 预后 Breast cancer susceptibility gene l Esophageal neoplasms Neoplasms, squamous cell Lymph nodes Neoplasms metastasis Prognosis
  • 相关文献

参考文献15

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin, 2012, 62:10-29.
  • 2Nusbaum R, Isaacs C. Management updates for women with a BRCA1 or BRCA2 mutation. Mol Diagn Ther, 2007, 11:133- 144.
  • 3Edlich RF, Winters KL, Lin KY. Breast cancer and ovarian cancer genetics. J Long Term Eft Med Implants, 2005, 15:533-545.
  • 4Rosen EM, Fan S, Goldberg ID, et al. BRCA1 and prostate cancer. Cancer Invest, 2001, 19:396-412.
  • 5Greer JB, Whitcomb DC. Role of BRCA1 and BRCA2 mutations in pancreatic cancer. Gut, 2007, 56:601-605.
  • 6史记,薛丽燕,尹宁,路军,付明,董立佳,邵淑娟,童彤,詹启敏.Aurora—A异常表达在食管鳞癌淋巴结转移中的作用[J].中华肿瘤杂志,2010,32(10):748-751. 被引量:7
  • 7Walsh T, Casadei S, Coats KH, et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA, 2006, 295:1379-1388.
  • 8Henderson BR. Regulation of BRCA1, BRCA2 and BARD1 intraeellular inatricking. Bioessays, 2005, 27:884-893.
  • 9Clover-Collins K, Thompson ME. Nuclear export of BRCA1 occurs during early S phase and is calcium-dependent. Cell Signal, 2008, 20:958-968.
  • 10Thompson ME. BRCA1 16 years later: nuclear import and export processes. FEBS, 2010, 277:3072-3078.

二级参考文献11

  • 1Miyoshi Y,Iwao K,Egawa C,et al.Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers.Int J Cancer,2001,92:370-373.
  • 2Tong T,Zhong Y,Kong J,et al.Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma.Clin Cancer Res,2004,10:7304-7310.
  • 3Tanaka E,Hashimoto Y,Ito T,et al.The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma.Clin Cancer Res,2005,11:1827-1834.
  • 4Bischoff JR,Anderson L,Zhu Y,et al.A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers.EMBO J,1998,17:3052-3065.
  • 5Sen S,Zhou H,Zhang RD,et al.Amplifieation/overexpression of a mitotic kinase gene in human bladder cancer.J Nail Cancer Inst,2002,94:1320-1329.
  • 6Li D,Zhu J,Firozi PF,et al.Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.Clin Cancer Res,2003,9:991-997.
  • 7Kurahashi T,Miyake H,Hara I,et al.Significance of Aurora-A expression in renal cell carcinoma.Urol Oncol,2007,25:128-133.
  • 8Zhang W,Wang J,Liu SJ,et al.Correlation between Aurora-A expression and the prognosis of cervical carcinoma patients.Acta Obstet Gyneeol Scand,2009,88:521-527.
  • 9邹丽娟,李国权,宋阳,郝立宏,宫琳琳,杨佩满,邵淑娟.Aurora-A激酶在肺癌中的表达[J].大连医科大学学报,2007,29(6):525-527. 被引量:2
  • 10张合林,刘瑞林,石彦涛,王志超,王保华,李永军,周连亚,平育敏.胸段食管癌切除术患者的预后分析[J].中华肿瘤杂志,2009,31(7):541-545. 被引量:27

共引文献6

同被引文献15

  • 1Jingsong Wang,Michael A. Maldonado.The Ubiquitin-Proteasome System and Its Role in Inflammatory and Autoimmune Diseases[J].Cellular & Molecular Immunology,2006,3(4):255-261. 被引量:38
  • 2Darius Ebrahimi-Fakhari,Lara Wahlster,Pamela McLean.??Protein degradation pathways in Parkinson’s disease: curse or blessing(J)Acta Neuropathologica . 2012 (2)
  • 3J. Kurashige,M. Watanabe,M. Iwatsuki.Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma. British Journal of Cancer . 2012
  • 4Akhoondi Shahab,Sun Dahui,von der Lehr Natalie,Apostolidou Sophia,Klotz Kathleen,Maljukova Alena,Cepeda Diana,Fiegl Heidi,Dafou Dimitra,Dofou Dimitra,Marth Christian,Mueller-Holzner Elisabeth,Corcoran Martin,Dagnell Markus,Nejad Sepideh Zabi.FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Research . 2007
  • 5Alan W. Lau,Hidefumi Fukushima,Wenyi Wei.The Fbw7 and Beta-TRCP E3 ubiquitin ligases and their roles in tumorigenesis. FRONTIERS IN BIOSCIENCE-LANDMARK . 2012
  • 6Milne A N,Leguit R,Corver W E,Morsink F H M,Polak M,de Leng W W,Carvalho R,Offerhaus G J A.Loss of CDC4/FBXW7 in gastric carcinoma. Cellular oncology : the official journal of the International Society for Cellular Oncology . 2010
  • 7Markus Welcker,Bruce E. Clurman.FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nature Reviews Cancer . 2008
  • 8Crusio K M,King B,Reavie L B,Aifantis I.The ubiquitous nature of cancer: the role of the SCF(Fbw7) complex in development and transformation. Oncegene . 2010
  • 9Kangsheng Tu,Xin Zheng,Guozhi Yin,Xianfeng Zan,Yingmin Yao,Qingguang Liu.??Evaluation of Fbxw7 expression and its correlation with expression ofSREBP-1 in a mouse model of NAFLD(J)Molecular Medicine Reports . 2012 (3)
  • 10Keiichi I. Nakayama,Keiko Nakayama.Ubiquitin ligases: cell-cycle control and cancer. Nature Reviews Cancer . 2006

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部